Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?

Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde? Intensive Care Med (2018) 44:1159–1161 https://doi.org/10.1007/s00134-018-5223-8 EDITORIAL Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde? 1* 2 Michael Joannidis and Eric Hoste © 2018 Springer-Verlag GmbH Germany, part of Springer Nature and ESICM Angiotensin-converting enzyme inhibitors (ACEIs) and These effects of ACEIs/ARBs, however, may become angiotensin receptor blockers (ARBs) are among the most highly unwanted in the situation of acute kidney injury frequently applied antihypertensive drugs. Their beneficial (AKI) where GFR has dropped because of a renal insult pleiotropic effects go far beyond blood pressure reduction. and a further reduction of GFR is clearly something treat- Remodeling of myocardium enhances the effects of after - ing physicians may want to avoid. This is even more rel - load reduction for the heart and makes ACEIs/ARBs a key evant in a situation where a patient is hemodynamically drug in treatment of chronic heart failure as well as for sec- unstable and ANG II inhibition hampers postglomeru- ondary prevention after acute myocardial infarction. With lar vasoconstriction which is key to preserving impaired regard to the kidney, ACEIs/ARBs have demonstrated to GFR. This effect is even more pronounced in patients reduce proteinuria and slow progression of CKD http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Intensive Care Medicine Springer Journals

Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?

Loading next page...
 
/lp/springer-journals/angiotensin-inhibition-in-patients-with-acute-kidney-injury-dr-jekyll-YbcKj6M7qT
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature and ESICM
Subject
Medicine & Public Health; Intensive / Critical Care Medicine; Anesthesiology; Emergency Medicine; Pneumology/Respiratory System; Pain Medicine; Pediatrics
ISSN
0342-4642
eISSN
1432-1238
D.O.I.
10.1007/s00134-018-5223-8
Publisher site
See Article on Publisher Site

Abstract

Intensive Care Med (2018) 44:1159–1161 https://doi.org/10.1007/s00134-018-5223-8 EDITORIAL Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde? 1* 2 Michael Joannidis and Eric Hoste © 2018 Springer-Verlag GmbH Germany, part of Springer Nature and ESICM Angiotensin-converting enzyme inhibitors (ACEIs) and These effects of ACEIs/ARBs, however, may become angiotensin receptor blockers (ARBs) are among the most highly unwanted in the situation of acute kidney injury frequently applied antihypertensive drugs. Their beneficial (AKI) where GFR has dropped because of a renal insult pleiotropic effects go far beyond blood pressure reduction. and a further reduction of GFR is clearly something treat- Remodeling of myocardium enhances the effects of after - ing physicians may want to avoid. This is even more rel - load reduction for the heart and makes ACEIs/ARBs a key evant in a situation where a patient is hemodynamically drug in treatment of chronic heart failure as well as for sec- unstable and ANG II inhibition hampers postglomeru- ondary prevention after acute myocardial infarction. With lar vasoconstriction which is key to preserving impaired regard to the kidney, ACEIs/ARBs have demonstrated to GFR. This effect is even more pronounced in patients reduce proteinuria and slow progression of CKD

Journal

Intensive Care MedicineSpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off